Efficacy and safety of combined low‐dose rituximab regimen for chronic inflammatory demyelinating polyradiculoneuropathy

Efficacy and safety of combined low‐dose rituximab regimen for chronic inflammatory demyelinating polyradiculoneuropathy

Abstract Objective To determine the efficacy and safety of combined low‐dose rituximab with conventional therapy for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) treatment. Methods Total 73 patients with CIDP were enrolled for the retrospective cohort study, and divided into conv...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ying Du, Qi Yan, Chuan Li, Wenping Zhu, Chao Zhao, Yunfeng Hao, Lin Li, Dan Yao, Xuan Zhou, Ying Li, Yuting Dang, Rong Zhang, Lin Han, Yuanyuan Wang, Tao Hou, Juan Li, Hailin Li, Panpan Jiang, Pei Wang, Fenying Chen, Tingge Zhu, Juntong Liu, Shuyu Liu, Lan Gao, Yingjun Zhao, Wei Zhang
Format:	Article
Language:	English
Published:	Wiley 2025-01-01
Series:	Annals of Clinical and Translational Neurology
Online Access:	https://doi.org/10.1002/acn3.52270
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A rare case of membranous nephropathy associated with chronic inflammatory demyelinating polyradiculoneuropathy
by: Qiong Zhang, et al.
Published: (2023-12-01)

Mitochondrial neurogastrointestinal encephalomyopathy mimicking chronic inflammatory demyelinating polyradiculoneuropathy
by: Camila Pupe, et al.
Published: (2012-03-01)

Stance Postural Strategies in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
by: Steno Rinalduzzi, et al.
Published: (2016-01-01)

A pathophysiological and mechanistic review of chronic inflammatory demyelinating polyradiculoneuropathy therapy
by: Marta Caballero-Ávila, et al.
Published: (2025-04-01)

Chronic idiopathic inflammatory demyelinating polyradiculoneuropathy: clinical, diagnostic and therapeutical evaluation
by: Maria Teresa Alves Hirata
Published: (1995-06-01)

Chronic inflammatory demyelinating polyradiculoneuropathy associated with Sjögren`s syndrome in a child
by: Nurşah Yeniay Süt, et al.
Published: (2023-02-01)

Intestinal microflora dysbiosis and resistome in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
by: Katia Djenadi, et al.
Published: (2024-09-01)

Chronic inflammatory demyelinating polyradiculoneuropathy (Austin-Dyck syndrome): study of 45 cases
by: Osvaldo José Moreira do Nascimento
Published: (1995-09-01)

ORGANISATION OF MEDICAL CARE FOR PATIENTS WITH RESPIRATORY FAILURE SUFFERING FROM INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY
by: D. N. Shishenkov, et al.
Published: (2017-12-01)

COMMENTS ON THE ARTICLE MANAGEMENT OF THE PATIENT WITH RESPIRATORY FAILURE SUFFERING FROM INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY
by: I. V. Vartanova, et al.
Published: (2017-12-01)

Chronic Inflammatory Demyelinating Polyradiculoneuropathy with Diplopia Caused by an Alternative Coronavirus Disease 2019 Vaccine
by: Satoshi Saito, et al.
Published: (2024-01-01)

Brazilian Academy of Neurology recommendations for diagnosis, management, and treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
by: Osvaldo J. M. Nascimento, et al.
Published: (2025-07-01)

Physician awareness and understanding of chronic inflammatory demyelinating polyradiculoneuropathy in Japan: a web-based study
by: Yukio Takeshita, et al.
Published: (2024-03-01)

WCN24-2707 Focal and Segmental Glomerulosclerosis and Chronic Inflammatory Demyelinating Polyradiculoneuropathy: a Case Report
by: Katia Olga Teresa Hernández Torres, et al.
Published: (2024-04-01)

Comparative multimodal sensory testing in multifocal motor neuropathy and multifocal variant of chronic inflammatory demyelinating polyradiculoneuropathy
by: T. A. Tumilovich, et al.
Published: (2024-03-01)

Neurophysiological differential diagnostic markers in hereditary neuropathy with liability to pressure palsies and chronic inflammatory demyelinating polyradiculoneuropathy
by: D. A. Grishina, et al.
Published: (2023-03-01)

Polirradiculoneuropatia desmielinizante inflamatória crônica: estudo de 18 pacientes Chronic inflammatory demyelinating polyradiculoneuropathy: study of 18 patients
by: Leandro C. Calia, et al.
Published: (1997-01-01)

Mitochondrial neurogastrointestinal encephalomyopathy mimicking chronic inflammatory demyelinating polyradiculoneuropathy Encefalomiopatia neurogastrointestinal mitocondrial mimetizando polirradiculoneuropatia inflamatória desmielinizante crônica
by: Camila Pupe, et al.
Published: (2012-03-01)

Efficacy and safety of a B-cell-driven rituximab regimen for the treatment of refractory idiopathic membranous nephropathy
by: Kaiqi Guo, et al.
Published: (2025-07-01)

EXPERIENCE IN THE USE OF PLASMAPHERESIS IN ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY GUILLAIN – BARRE SYNDROME IN THE PATIENT WITH CHRONIC HEPATITIS C VIRUS INFECTION AND TYPE 2 DIABETES MELLITUS
by: V. A. Voinov, et al.
Published: (2018-12-01)

Chronic inflammatory demyelinating polyradiculoneuropathy: two cases with cervical spinal cord compression Polirradiculoneuropatia desmielinizante inflamatória crônica: dois casos com síndrome de compressão medular
by: Marcos R.G. de Freitas, et al.
Published: (2005-09-01)

Can quantitative monitoring of B cells evaluate the efficacy of Rituximab in primary CNS demyelinating disorders?
by: Sayan Chatterjee, et al.
Published: (2024-01-01)

Clinical evaluation of tremor in chronic inflammatory demy-elinating polyradiculoneuropathy
by: Denise Hack Nicaretta
Published: (1995-12-01)

Pourradiculoneurite e neurocisticercose: relato de caso Polyradiculoneuropathy and neurocysticercosis: case report
by: Svetlana Agapejev, et al.
Published: (1996-03-01)

SGK1 drives hippocampal demyelination and diabetes-associated cognitive dysfunction in mice
by: Ziying Jiang, et al.
Published: (2025-02-01)

Dynamic Transcriptomic and Cellular Remodeling Underlie Cuprizone-Induced Demyelination and Endogenous Repair in the CNS
by: Yantuanjin Ma, et al.
Published: (2025-06-01)

Successful sequential therapy with rituximab and telitacicept in refractory Anti-NMDA receptor encephalitis and MOG-associated demyelination: a case report and literature review
by: Jingliang Zhang, et al.
Published: (2025-02-01)

Ultra-low-dose rituximab is effective for the treatment of patients with minimal change disease - A retrospective study
by: Chang Wang, et al.
Published: (2025-07-01)

Tumefactive Demyelination Lesions: Report on Three Cases
by: Chi-Ju Lin, et al.
Published: (2024-10-01)

Identifying Tumefactive Demyelination on Synthetic MRI Myelin Maps
by: Brandon Simons, et al.
Published: (2025-01-01)

Phenotyping Healthcare Use 2–3 Decades Before the First Multiple Sclerosis Demyelinating Event
by: Helen Tremlett, et al.
Published: (2025-08-01)

Polyradiculoneuropathy of Guillain-Barre ’ during pregnancy: a case report of a successful maternal and fetal outcome
by: A. Benjilany, et al.
Published: (2022-02-01)

Experimental neurocysticercosis and demyelination
by: Pedro Tadao HAMAMOTO FILHO, et al.

Osmotic Demyelinating Syndrome
by: G. R. Ramazanov, et al.
Published: (2020-10-01)

Inflammatory Demyelinating Polyradiculopathy
by: J Gordon Millichap
Published: (1998-09-01)

Efficacy and safety of belimumab versus rituximab for refractory immune thrombocytopenia in patients with connective tissue disease
by: Min Wang, et al.
Published: (2025-05-01)

The monitoring of B lymphocytes in non-lymphoma patients following rituximab treatment
by: Linjie Dong, et al.
Published: (2024-11-01)

The Correlation between Aquaporin-4 Antibody and the Visual Function of Patients with Demyelinating Optic Neuritis at Onset
by: Hui Yang, et al.
Published: (2015-01-01)

Meta-analysis of the efficacy and safety of rituximab in the treatment of primary Sjögren’s syndrome
by: Xiao Zheng, et al.
Published: (2025-06-01)

A meta-analysis of the efficacy of rituximab in the treatment of refractory nephrotic syndrome
by: Liu Wu, et al.
Published: (2021-01-01)